Biovotion AG

Biovotion AG

Biovotion AG was established as a Swiss medical technology company that developed wearable health monitoring systems, later transitioning into an asset management firm focused on digital health investments. The firm's founding team, based on public records, originated from ETH Zurich and brought deep expertise in biosensor technology and clinical trial design. The firm now concentrates on digital health and MedTech, investing across wearable devices, AI-driven diagnostics, remote patient monitoring platforms, and healthcare data analytics. Public records indicate Biovotion's portfolio includes companies developing continuous vital sign monitoring solutions and cloud-based clinical decision support tools—though specific portfolio company names are not consistently disclosed in public sources. The firm operates across North America, Europe, and Asia, with offices in Menlo Park, Boston, London, Singapore, and Zurich. Biovotion's total assets under management are not publicly disclosed, and the number of investment professionals has not been confirmed. The firm maintains a multi-office operational structure spanning five global cities, suggesting a geographically distributed team. No recent operational events have been publicly reported in the last 24 months. A key structural differentiator for Biovotion is its evolution from a technology developer to an asset manager—a trajectory that gives it in-house technical expertise in wearable biosensors and clinical validation, rather than relying solely on external due diligence. This vertical integration into the digital health value chain creates a distinct sourcing and evaluation advantage, but also limits its addressable universe to a narrow segment of the healthcare technology market.